10-Q/A Filing

GLOBAL MEDICAL REIT INC. CIK: 1533615 Q1 2014

Filing Information

Form Type	10-Q/A
Accession Number	`0001078782-14-000068`
Period End Date	20131130
Filing Date	20140116
Fiscal Year	2014
Fiscal Period	Q1
XBRL Instance	scoo-20131130.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 28 Income Statement 15 Cash Flow Statement 40

Balance Sheet 28 line items

Line Item	Tag	Value	Unit	Period
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash	`Cash`	$3.52K	USD	Point-in-time
Cash	`Cash`	$3.47K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$3.47K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	8.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$3.52K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	8.00M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	8.00M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	8.00M	shares	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$21.14K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$19.04K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$5.89K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$380.00	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$27.04K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$19.42K	USD	Point-in-time
Common stock Authorized: 200,000,000 shares, par value $0.001 , 8,000,000 and 5,500,000 share issued and outstanding, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Common stock Authorized: 200,000,000 shares, par value $0.001 , 8,000,000 and 5,500,000 share issued and outstanding, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$72.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$72.00K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-103.57K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-95.91K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$-23.57K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$15.90K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$3.52K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$3.47K	USD	Point-in-time

Income Statement 15 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`GeneralAndAdministrativeExpense`	$103.57K	USD	11 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$7.67K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$27.62K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$103.57K	USD	11 Qtrs
Total Operating Expenses	`OperatingExpenses`	$7.67K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$27.62K	USD	1 Quarter
Net Loss	`ProfitLoss`	$-103.57K	USD	11 Qtrs
Net Loss	`ProfitLoss`	$-27.62K	USD	1 Quarter
Net Loss	`ProfitLoss`	$-7.67K	USD	1 Quarter
Net Loss Per Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net Loss Per Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net Loss Per Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	11 Qtrs
Weighted Average Shares Outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	0.00	shares	11 Qtrs
Weighted Average Shares Outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.00M	shares	1 Quarter
Weighted Average Shares Outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.31M	shares	1 Quarter

Cash Flow Statement 40 line items

Line Item	Tag	Value	Unit	Period
Net loss for the period	`NetIncomeLoss`	$-27.62K	USD	1 Quarter
Net loss for the period	`NetIncomeLoss`	$-7.67K	USD	1 Quarter
Net loss for the period	`NetIncomeLoss`	$-103.57K	USD	11 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	11 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.50K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$21.14K	USD	11 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$2.10K	USD	1 Quarter
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.57K	USD	1 Quarter
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-82.43K	USD	11 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-26.12K	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$80.00K	USD	11 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$25.00K	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from related party debt	`ProceedsFromRelatedPartyDebt`	-	USD	1 Quarter
Proceeds from related party debt	`ProceedsFromRelatedPartyDebt`	$5.51K	USD	1 Quarter
Proceeds from related party debt	`ProceedsFromRelatedPartyDebt`	$5.89K	USD	11 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$5.51K	USD	1 Quarter
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$25.00K	USD	1 Quarter
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$85.89K	USD	11 Qtrs
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-53.00	USD	1 Quarter
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.47K	USD	11 Qtrs
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.12K	USD	1 Quarter
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$3.52K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$3.47K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$12.31K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.19K	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$3.52K	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$3.47K	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$12.31K	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.19K	USD	Point-in-time
Interest paid	`InterestPaid`	-	USD	1 Quarter
Interest paid	`InterestPaid`	-	USD	1 Quarter
Interest paid	`InterestPaid`	-	USD	11 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	11 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.